SCHEMBL721757

SCHEMBL721757

O=C(O)C1(Cl)N=C(Cl)C=CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL13518129 0.71 HCAR3 (0.32)
SCHEMBL10635305 0.69
SCHEMBL3445966 0.61
SCHEMBL19614414 0.58
SCHEMBL27449966 0.58
SCHEMBL666988 0.58
SCHEMBL8588963 0.51
1,3,5-Trichlorobenzene SCHEMBL28758659 0.49 TPMT (0.57)
SCHEMBL9354655 0.48
Acetic Acid SCHEMBL208214 0.48 GSK3A (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102448939-A Nicotinamide derivatives, their preparation and their therapeutic use as anticancer agents SANOFI AVENTIS 2012-05-09 CN disclosed
US-20120094986-A1 ANTICANCER DERIVIATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2012-04-19 US disclosed
US-20120053209-A1 ANTICANCER COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-01 US disclosed
US-20120053170-A1 NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF AS ANTICANCER DRUGS SANOFI (FR) 2012-03-01 US disclosed